the Royal Brompton and Harefield NHS Trust, London, UK.
J Allergy Clin Immunol. 2012 Apr;129(4):974-82.e13. doi: 10.1016/j.jaci.2012.01.059. Epub 2012 Mar 3.
The pathology of pediatric severe therapy-resistant asthma (STRA) is little understood.
We hypothesized that STRA in children is characterized by airway eosinophilia and mast cell inflammation and is driven by the T(H)2 cytokines IL-4, IL-5, and IL-13.
Sixty-nine children (mean age, 11.8 years; interquartile range, 5.6-17.3 years; patients with STRA, n = 53; control subjects, n = 16) underwent fiberoptic bronchoscopy, bronchoalveolar lavage (BAL), and endobronchial biopsy. Airway inflammation, remodeling, and BAL fluid and biopsy specimen T(H)2 cytokines were quantified. Children with STRA also underwent symptom assessment (Asthma Control Test), spirometry, exhaled nitric oxide and induced sputum evaluation.
Children with STRA had significantly increased BAL fluid and biopsy specimen eosinophil counts compared with those found in control subjects (BAL fluid, P < .001; biopsy specimen, P < .01); within the STRA group, there was marked between-patient variability in eosinophilia. Submucosal mast cell, neutrophil, and lymphocyte counts were similar in both groups. Reticular basement membrane thickness and airway smooth muscle were increased in patients with STRA compared with those found in control subjects (P < .0001 and P < .001, respectively). There was no increase in BAL fluid IL-4, IL-5, or IL-13 levels in patients with STRA compared with control subjects, and these cytokines were rarely detected in induced sputum. Biopsy IL-5(+) and IL-13(+) cell counts were also not higher in patients with STRA compared with those seen in control subjects. The subgroup (n = 15) of children with STRA with detectable BAL fluid T(H)2 cytokines had significantly lower lung function than those with undetectable BAL fluid T(H)2 cytokines.
STRA in children was characterized by remodeling and variable airway eosinophil counts. However, unlike in adults, there was no neutrophilia, and despite the wide range in eosinophil counts, the T(H)2 mediators that are thought to drive allergic asthma were mostly absent.
儿科重症治疗抵抗性哮喘(STRA)的病理学尚不清楚。
我们假设儿童 STRA 的特征是气道嗜酸性粒细胞增多和肥大细胞炎症,并由 T(H)2 细胞因子 IL-4、IL-5 和 IL-13 驱动。
69 名儿童(平均年龄 11.8 岁;四分位间距 5.6-17.3 岁;STRA 患儿 53 例,对照组 16 例)行纤维支气管镜检查、支气管肺泡灌洗(BAL)和支气管内膜活检。定量检测气道炎症、重塑以及 BAL 液和活检标本中的 T(H)2 细胞因子。STRA 患儿还进行了症状评估(哮喘控制测试)、肺功能、呼出气一氧化氮和诱导痰评估。
与对照组相比,STRA 患儿的 BAL 液和活检标本中的嗜酸性粒细胞计数明显增加(BAL 液,P <.001;活检标本,P <.01);在 STRA 组内,嗜酸性粒细胞增多存在显著的个体间变异性。两组的黏膜下肥大细胞、中性粒细胞和淋巴细胞计数无差异。与对照组相比,STRA 患儿的网状基底膜厚度和气道平滑肌均增加(P <.0001 和 P <.001)。与对照组相比,STRA 患儿的 BAL 液中 IL-4、IL-5 或 IL-13 水平无升高,且这些细胞因子在诱导痰中很少被检测到。与对照组相比,活检 IL-5(+)和 IL-13(+)细胞计数在 STRA 患儿中也没有升高。在可检测到 BAL 液 T(H)2 细胞因子的 STRA 患儿亚组(n = 15)中,肺功能明显低于无法检测到 BAL 液 T(H)2 细胞因子的患儿。
儿童 STRA 的特征是重塑和气道嗜酸性粒细胞计数的可变性。然而,与成人不同,没有嗜中性粒细胞增多,尽管嗜酸性粒细胞计数范围广泛,但被认为驱动过敏性哮喘的 T(H)2 介质大多不存在。